Natco Pharma

{{Short description|Indian pharmaceutical company}}

{{Use dmy dates|date=June 2022}}

{{Use Indian English|date=June 2022}}

{{Infobox company

| name = Natco Pharma

| logo = Natco Pharma Logo.svg

| logo_size =

| caption =

| type = Public

| genre =

| traded_as = {{NSE|NATCOPHARM}}
{{BSE|524816}}

| predecessor =

| successor =

| foundation = 1981

| founder = VC Nannapaneni

| defunct =

| location_city = Hyderabad, Telangana

| location_country = India

| locations =

| area_served = Global

| key_people = VC Nannapaneni (Chairman and MD){{cite news |title=Facing headwinds in US, Natco Pharma looks to scale up business in China |url=https://www.livemint.com/companies/news/facing-headwinds-in-us-natco-pharma-looks-to-scale-up-business-in-china-1565511497326.html |accessdate=19 April 2020 |work=Livemint}}
Rajeev Nannapaneni (CEO and Vice Chairman){{cite news |title=Natco Pharma: In fine fettle |url=https://www.forbesindia.com/article/super-50-companies-2018/natco-pharma-in-fine-fettle/51067/1 |accessdate=19 April 2020 |work=Forbes India}}

| industry = Pharmaceuticals

| products =

| services =

| revenue = {{up}} {{INRconvert|4127|c}} (FY24){{Cite web| title=Q4 FY2024 Investors Presentation | url=https://www.natcopharma.co.in/wp-content/uploads/2024/05/Q4EarningsPresentation2024.pdf | archive-url=https://web.archive.org/web/20240628124204/https://www.natcopharma.co.in/wp-content/uploads/2024/05/Q4EarningsPresentation2024.pdf | archive-date=2024-06-28}}

| operating_income =

| net_income = {{up}} {{INRconvert|1388|c}} (FY24){{Cite web| title=Q4 FY2024 Investors Presentation | url=https://www.natcopharma.co.in/wp-content/uploads/2024/05/Q4EarningsPresentation2024.pdf | archive-url=https://web.archive.org/web/20240628124204/https://www.natcopharma.co.in/wp-content/uploads/2024/05/Q4EarningsPresentation2024.pdf | archive-date=2024-06-28}}

| aum =

| assets =

| equity =

| owner =

| num_employees =

| parent =

| divisions =

| homepage = [http://www.natcopharma.co.in natcopharma.co.in]

| footnotes =

}}

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products.{{Cite web |title=Our Business {{!}} Natco Pharma |url=https://www.natcopharma.co.in/our-business/ |access-date=2022-04-25}} It is a major producer of branded oncology medicines{{cite news |title=Natco Pharma lines up 20 'Para IV' products |url=https://www.thehindubusinessline.com/companies/natco-pharma-lines-up-20-para-iv-products/article29408594.ece |accessdate=19 April 2020 |work=The Hindu Business Line}} cardiology, diabetology and other pharma specialty drugs at affordable prices.{{Cite news |last=PTI |date=17 December 2020 |title=Natco Pharma launches anti blood clot medication, Rivaroxaban, in India |work=The Economic Times |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-launches-anti-blood-clot-medication-rivaroxaban-in-india/articleshow/79779503.cms?from=mdr |access-date=2022-04-25}}{{Cite web |last=Akolkar |first=Shrikant |date=9 March 2017 |title=Natco Pharma: Top league player |url=https://www.angelone.in/get-co-pdf/AngelBrokingResearch_NatcoPharma_Inititatingcoverage_090317.pdf |access-date=25 April 2022 |website=Angel One}}{{Cite web |title=Mission & Heritage {{!}} Natco Pharma |url=https://www.natcopharma.co.in/about/mission-heritage/ |access-date=2022-04-25}}{{Cite web |last=Sridhar |first=G. Naga |date=2020-11-25 |title=Natco Pharma expects agri business to be key growth lever |url=https://www.thehindubusinessline.com/companies/natco-pharma-expects-agri-business-to-be-key-growth-lever/article33175348.ece |access-date=2022-04-24 |website=www.thehindubusinessline.com |language=en}}